There is no descriptive and functional data on protein levels of GRP78 in the bone marrow of patients with plasma cell disorders, such as monoclonal gammopathy of undetermined significance (MGUS, a premalignant condition ultimately leading to MM), newly diagnosed MM (NDMM) and relapsed/refractory MM (RRMM). This evidence concerns the gene HSPA5 and plasma cell neoplasm.